MedKoo Cat#: 205653 | Name: D-3263 free base
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

D-3263 is a TRPM8 agonist ( transient receptor potential melastatin member 8) with potential antineoplastic activity. The active ingredient in enteric-coated TRPM8 agonist D-3263 hydrochloride binds to and activates TRPM8, which may result in an increase in calcium and sodium entry; the disruption of calcium and sodium homeostasis; and the induction of cell death in TRPM8-expressing tumor cells.

Chemical Structure

D-3263 free base
D-3263 free base
CAS#947257-66-1 (free base)

Theoretical Analysis

MedKoo Cat#: 205653

Name: D-3263 free base

CAS#: 947257-66-1 (free base)

Chemical Formula: C21H31N3O3

Exact Mass: 373.2365

Molecular Weight: 373.50

Elemental Analysis: C, 67.53; H, 8.37; N, 11.25; O, 12.85

Price and Availability

Size Price Availability Quantity
50mg USD 1,950.00 2 Weeks
100mg USD 2,650.00 2 Weeks
200mg USD 3,950.00 2 Weeks
500mg USD 5,950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
D3263; D 3263; D-3263;
IUPAC/Chemical Name
3-(2-aminoethyl)-1-((1R,2S,5R)-2-isopropyl-5-methylcyclohexane-1-carbonyl)-5-methoxy-1,3-dihydro-2H-benzo[d]imidazol-2-one
InChi Key
ZGTYTFYRCIRWBL-HYVNUMGLSA-N
InChi Code
InChI=1S/C21H31N3O3/c1-13(2)16-7-5-14(3)11-17(16)20(25)24-18-8-6-15(27-4)12-19(18)23(10-9-22)21(24)26/h6,8,12-14,16-17H,5,7,9-11,22H2,1-4H3/t14-,16+,17-/m1/s1
SMILES Code
O=C1N(C([C@H]2[C@H](C(C)C)CC[C@@H](C)C2)=O)C3=CC=C(OC)C=C3N1CCN
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not soluble in water.
Shelf Life
>5 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
 This agent may decrease dihydrotestosterone (DHT) levels, which may contribute to its inhibitory effects on prostate cancer and BPH. TRPM8 is a transmembrane calcium channel protein that is normally expressed in prostate cells and appears to be overexpressed in benign prostatic hyperplasia (BPH) and in prostate cancer. TRPM8 (also known as TRPP8)  is an ion channel that is triggered by cold temperatures and small-molecule agonists and belongs to the melastatin subfamily - one of seven subfamilies of TRP proteins. In normal human tissues, TRPM8 is expressed predominantly in the prostate, a gland in the male reproductive system. It is over-expressed in prostate hyperplasia and multiple types of cancer including prostate cancer, breast cancer, colon cancer and lung cancer. In recent years, it has emerged that TRP channels play a diverse and key role in cell biology and in pathology. Dendreon has synthesized small molecule agonists including D3263 that activate the TRPM8 ion channel and induce cell death. ( source: http://www.dendreon.com/research-development/trpm8/).      

Preparing Stock Solutions

The following data is based on the product molecular weight 373.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. 5-Benzyloxytryptamine as an antagonist of TRPM8 By DeFalco, Jeff; Steiger, Daniel; Dourado, Michelle; Emerling, Daniel; Duncton, Matthew A. J. From Bioorganic & Medicinal Chemistry Letters (2010), 20(23), 7076-7079. 2. Small-molecule modulators of Trp-p8 activity By Moreno, Ofir; Natarajan, Sateesh; Duncan, David F. From PCT Int. Appl. (2009), WO 2009067410 A1 20090528. 3. Small-molecule modulators of Trp-p8 activity By Moreno, Ofir; Natarajan, Sateesh; Duncan, David F. From U.S. Pat. Appl. Publ. (2008), US 20080255185 A1 20081016. 4. Preparation of menthylcarbonylbenzimidazolones and related compounds modulators of Trp-p8 (transient receptor potential-p8) activity By Moreno, Ofir; Natarajan, Sateesh; Duncan, David F. From PCT Int. Appl. (2007), WO 2007095340 A2 20070823.